SELL Kotak Mahindra Bank Ltd. — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))4 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Press Release on annual audited financial results attached
BSE · Company Update·2 May · 1w ago
Kotak Mahindra Bank's Board of Directors has approved the consolidated and standalone audited financial results for the financial year ended March 31, 2026. The auditors' report contains an unmodified
BSE · Result·2 May · 1w ago
Kotak Mahindra Bank Limited's Board of Directors has approved the consolidated and standalone audited financial results for the financial year ended March 31, 2026. The results have been reviewed by t
NSE · Outcome of Board Meeting·2 May · 1w ago
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·8 May · 3d ago
Kotak Mahindra Bank announced its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. Standalone PAT increased by 2% YoY to ₹14,008 crore, and consolidated
NSE · Press Release·2 May · 1w ago
The Board of Directors of Kotak Mahindra Bank Ltd has recommended a dividend of Re. 0.65 per equity share of face value Re. 1/-.
BSE · Company Update·2 May · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Kotak Mahindra Bank
- BUY — Ruchit Jain, Motilal Oswal22 Oct 2026 · ~2 weeks · target ₹452 · SL hit
- BUY — Chandan Taparia, Motilal Oswal19 Oct 2026 · ~2 weeks · target ₹465 · Active
- BUY — Ajit Mishra, Religare16 Oct 2026 · ~2 weeks · target ₹471 · SL hit
- BUY — Ajit Mishra, Religare16 Oct 2026 · ~2 weeks · target ₹470 · SL hit
- BUY — Ruchit Jain, Motilal Oswal16 Oct 2026 · ~2 weeks · target ₹471 · SL hit
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

